Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: Analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study

Nicola Fazio, Dan Granberg, Ashley Grossman, Stephen Saletan, Judith Klimovsky, Ashok Panneerselvam, Edward M. Wolin

Research output: Contribution to journalArticlepeer-review

76 Scopus citations

Fingerprint Dive into the research topics of 'Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: Analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences